176 related articles for article (PubMed ID: 25173085)
1. Dosimetric benefits of placing dose constraints on the brachial plexus in patients with nasopharyngeal carcinoma receiving intensity-modulated radiation therapy: a comparative study.
Jiang H; Lu H; Yuan H; Huang H; Wei Y; Zhang Y; Liu X
J Radiat Res; 2015 Jan; 56(1):114-21. PubMed ID: 25173085
[TBL] [Abstract][Full Text] [Related]
2. A dosimetric evaluation on applying RTOG-based and CT/MRI-based delineation methods to brachial plexus in radiotherapy of nasopharyngeal carcinoma treated with helical tomotherapy.
Li CH; Wu VW; Chiu G
Br J Radiol; 2019 Oct; 92(1102):20170881. PubMed ID: 29714086
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose to the brachial plexus in head-and-neck intensity-modulated radiation therapy and its relationship to tumor and nodal stage.
Truong MT; Romesser PB; Qureshi MM; Kovalchuk N; Orlina L; Willins J
Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):158-64. PubMed ID: 22300574
[TBL] [Abstract][Full Text] [Related]
4. Brachial plexus dose tolerance in head and neck cancer patients treated with sequential intensity modulated radiation therapy.
Thomas TO; Refaat T; Choi M; Bacchus I; Sachdev S; Rademaker AW; Sathiaseelan V; Karagianis A; Mittal BB
Radiat Oncol; 2015 Apr; 10():94. PubMed ID: 25927572
[TBL] [Abstract][Full Text] [Related]
5. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
6. Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.
White P; Chan KC; Cheng KW; Chan KY; Chau MC
J Radiat Res; 2013 May; 54(3):532-45. PubMed ID: 23188186
[TBL] [Abstract][Full Text] [Related]
7.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
8. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy.
Huang H; Lu H; Feng G; Jiang H; Chen J; Cheng J; Pang Q; Lu Z; Gu J; Peng L; Deng S; Mo Y; Wu D; Wei Y
Radiat Oncol; 2015 Sep; 10():192. PubMed ID: 26377685
[TBL] [Abstract][Full Text] [Related]
9. Will weight loss cause significant dosimetric changes of target volumes and organs at risk in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy?
Chen C; Fei Z; Chen L; Bai P; Lin X; Pan J
Med Dosim; 2014; 39(1):34-7. PubMed ID: 24140235
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the dosimetric feasibility of hippocampal sparing intensity-modulated radiotherapy in patients with locally advanced nasopharyngeal carcinoma.
Han G; Liu D; Gan H; Denniston KA; Li S; Tan W; Hu D; Zhen W; Wang Z
PLoS One; 2014; 9(2):e90007. PubMed ID: 24587184
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated radiotherapy increases dose to the brachial plexus compared with conventional radiotherapy for head and neck cancer.
Chen AM; Hall WH; Li BQ; Guiou M; Wright C; Mathai M; Dublin A; Purdy JA
Br J Radiol; 2011 Jan; 84(997):58-63. PubMed ID: 20858665
[TBL] [Abstract][Full Text] [Related]
12. Constraining the brachial plexus does not compromise regional control in oropharyngeal carcinoma.
Mutter RW; Lok BH; Dutta PR; Riaz N; Setton J; Berry SL; Goenka A; Zhang Z; Rao SS; Wolden SL; Lee NY
Radiat Oncol; 2013 Jul; 8():173. PubMed ID: 23835205
[TBL] [Abstract][Full Text] [Related]
13. Advanced nasopharyngeal carcinoma radiotherapy with volumetric modulated arcs and the potential role of flattening filter-free beams.
Zhuang M; Zhang T; Chen Z; Lin Z; Li D; Peng X; Qiu Q; Wu R
Radiat Oncol; 2013 May; 8():120. PubMed ID: 23672519
[TBL] [Abstract][Full Text] [Related]
14. Validating the RTOG-endorsed brachial plexus contouring atlas: an evaluation of reproducibility among patients treated by intensity-modulated radiotherapy for head-and-neck cancer.
Yi SK; Hall WH; Mathai M; Dublin AB; Gupta V; Purdy JA; Chen AM
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1060-4. PubMed ID: 21536393
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of hippocampus dose for patients undergoing intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Khodayari B; Michaud AL; Stanic S; Wooten OH; Dublin A; Purdy JA; Chen AM
Br J Radiol; 2014 May; 87(1037):20130474. PubMed ID: 24620838
[TBL] [Abstract][Full Text] [Related]
16. Dose planning study of target volume coverage with intensity- modulated radiotherapy for nasopharyngeal carcinoma: Penang General Hospital experience.
Phua Chee Ee V; Tan BS; Tan AL; Eng KY; Ng BS; Ung NM
Asian Pac J Cancer Prev; 2013; 14(4):2243-8. PubMed ID: 23725120
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiotherapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation.
Kam MK; Chau RM; Suen J; Choi PH; Teo PM
Int J Radiat Oncol Biol Phys; 2003 May; 56(1):145-57. PubMed ID: 12694833
[TBL] [Abstract][Full Text] [Related]
18. Interobserver variations in the delineation of target volumes and organs at risk and their impact on dose distribution in intensity-modulated radiation therapy for nasopharyngeal carcinoma.
Peng YL; Chen L; Shen GZ; Li YN; Yao JJ; Xiao WW; Yang L; Zhou S; Li JX; Cheng WQ; Guan Y; Xia HQ; Liu S; Zhao C; Deng XW
Oral Oncol; 2018 Jul; 82():1-7. PubMed ID: 29909882
[TBL] [Abstract][Full Text] [Related]
19. Dose--volume modeling of brachial plexus-associated neuropathy after radiation therapy for head-and-neck cancer: findings from a prospective screening protocol.
Chen AM; Wang PC; Daly ME; Cui J; Hall WH; Vijayakumar S; Phillips TL; Farwell DG; Purdy JA
Int J Radiat Oncol Biol Phys; 2014 Mar; 88(4):771-7. PubMed ID: 24606846
[TBL] [Abstract][Full Text] [Related]
20. Reducing the risk of xerostomia and mandibular osteoradionecrosis: the potential benefits of intensity modulated radiotherapy in advanced oral cavity carcinoma.
Ahmed M; Hansen VN; Harrington KJ; Nutting CM
Med Dosim; 2009; 34(3):217-24. PubMed ID: 19647632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
